| Date | Title | Description |
| 17.02.2026 | Американский биотех-конгломерат Danaher покупает производителя пульсоксиметров Masimo за $9,9 млрд | Во вторник компании сообщили, что Danaher заплатит $180 за акцию Masimo. Это предложение предполагает премию в 38,3% к цене закрытия акций Masimo на предыдущей сессии.
Это крупнейшая сделка Danaher с момента покупки в 2023 году производител... |
| 14.01.2026 | Nuclera Accelerates AI-Driven Antibody Engineering with $87 Million Capital Infusion | Nuclera secures an additional $12 million, elevating Series C funding to $87 million. This critical capital fuels accelerated antibody engineering on its eProtein Discovery benchtop system. The biotech leader targets AI-enabled protein deve... |
| 13.01.2026 | Nuclera extends Series C funding to $87M to advance antibody engineering | Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh
The funding will accelerate development of eProtein Discovery for full-format antibody expressi... |
| 13.01.2026 | Nuclera Extends Series C Funding To $87 Million To Advance Antibody Engineering | Nuclera, a biotech company developing a benchtop platform for rapid access to functional proteins, has raised a $12 million extension to its Series C financing, bringing total Series C funding to $87 million.
The extension was led by Elevag... |
| 13.01.2026 | UK’s Nuclera brings Series C funding to €74 million following €10 million extension for its eProtein Discovery system | Cambridge-based Nuclera, a BioTech company accelerating drug discovery by providing access to functional proteins through its benchtop eProtein Discovery System, today announced a €10 million ($12 million) financing extension, bringing the ... |
| 15.12.2025 | FinQuery Accelerates Momentum With 19th Consecutive Quarter as the Top-Ranked Lease Accounting Software | FinQuery, a leading provider of AI-powered accounting automation software, announced today that its lease accounting solution, LeaseQuery, earned the No. 1 position on G2’s Lease Accounting Software Grid for the 19th consecutive quarter. Th... |
| 01.08.2025 | VC firm Cambridge Innovation Capital commits €115 million to back University of Cambridge spinouts | Cambridge Innovation Capital (CIC), the VC firm investing in British high-potential DeepTech and life sciences companies, announced they are committing at least €115 million to invest in spinouts from the University of Cambridge.
This inves... |
| 24.06.2025 | Cambridge science has global ambitions and London is our departure lounge | Cambridge is seizing a unique moment to amplify the global impact of its world-leading research by opening a new office in London’s tech hub, aiming to build stronger connections, embrace entrepreneurial risk, and better integrate academia ... |
| 10.03.2025 | Cambridge Innovation Capital: £100 Million Opportunity Fund Closed | Cambridge Innovation Capital (CIC), a leading venture capital firm embedded in the Cambridge ecosystem, announced it has launched a new £100 million Opportunity Fund – which is anchored by Aviva Investors and British Patient Capital – to in... |
| 24.02.2025 | Cambridge Innovation Capital launches £100m Opportunity Fund | Aviva Investors and British Patient Capital lead investment into new growth fund addressing the UK’s scale-up funding gap.
24 February 2025, Cambridge, UK — Cambridge Innovation Capital (CIC), the leading venture capital firm embedded in th... |
| 24.02.2025 | Cambridge Innovation Capital launches £100M Fund for deeptech and life sciences | Cambridge Innovation Capital (CIC) has today launched a new £100 million Opportunity Fund to invest in growth stage deep tech and life sciences companies.
With up to £20 million per investment into later-stage rounds of deep tech and life s... |
| 29.01.2025 | Quibim's Leap into the U.S. Market: A $50M Investment in Precision Medicine | In the world of health technology, precision is paramount. Quibim, a Valencia-based healthtech company, has just secured a significant $50 million in Series A financing. This funding is not just a number; it’s a lifeline aimed at transformi... |
| 28.01.2025 | HealthTech Quibim’s vision for human digital twins gets €47.9M boost | Quibim, a Valencia-based HealthTech company innovating the use of imaging biomarkers for precision medicine, announced today the close of its €47.9 million Series A financing in order establish US presence.
The financing was led by Asabys (... |
| 27.01.2025 | Understanding Antibody Structure: A Comprehensive Guide for Beginners | Antibodies are key components of the immune system. They act as the body’s defense system against invading pathogens such as bacteria and viruses. Basically, antibodies are proteins that are formed by the immune system to protect the body f... |
| 30.12.2024 | University of Cambridge Enterprise Fund X launch |
We are delighted to announce the launch of our University of Cambridge Enterprise Fund (UCEF) X. The Fund is managed by Parkwalk in conjunction with Cambridge Enterprise, the university’s research commercialisation arm, backing the very be... |
| 30.12.2024 | Recombinant Antibodies and Its Production Process | Created by Carl Williams
Updated: Dec 30 2024, 19:52 PM EST
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 19.12.2024 | bit.bio raises $30 Million led by M&G Investments | bit.bio raises $30 Million led by M&G Investments to focus on tools for the research, drug discovery and cell therapy markets.
Jonathan Milner appointed Interim CEO; Mark Kotter assumes Vice Chairman role as Company expands Board with d... |
| 06.12.2024 | Revolut, Interactive Investor and Abcam: Britain’s venture capital success stories | - |
| 15.10.2024 | clock.bio: Healthspan Biotech Company Secures $5.3 Million (Seed) | Healthspan biotech company clock.bio announced it has raised $5.3 million in seed funding, led by LocalGlobe and with participation from BlueYard Capital, Onsight Ventures, and Dr. Jonathan Milner (the founder of Abcam). The company made si... |
| 10.10.2024 | clock.bio Raises $5.3M to Decode Human Rejuvenation, Develop Anti-Aging Therapies | What You Should Know:
– clock.bio, a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to advance its groundbreaking research on human rejuvenation.
– The seed fundin... |
| 13.09.2024 | The New Wave of Healthcare Innovation: Leaders Shaping the Future | The healthcare landscape is evolving. Two recent appointments highlight this shift. Closed Loop Medicine and Highlander Health are at the forefront, steering the ship toward a more personalized and efficient future. Closed Loop Medicine, a ... |
| 11.09.2024 | Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors | Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones
London, UK, 11 Sep 2024: Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine le... |
| 29.07.2024 | Predicta Biosciences: Pioneering a New Era in Cancer Diagnostics | Predicta Biosciences is making waves in the ocean of cancer diagnostics. With a fresh infusion of $5.2 million in seed funding, this Boston-based precision oncology company is poised to change the landscape of how we detect and treat blood ... |
| 27.07.2024 | Predicta Biosciences Raises $5.2 Million To Develop Novel Diagnostic And Therapeutic Products | Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, announced it had raised an oversubscribed $5.2 million seed round led by The Engine Ventures. And additional participating investors in... |
| 18.03.2024 | Abcam appoints Markus Lusser as new President | CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.
Markus Lusser, President of Abcam
A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company tr... |
| 09.03.2024 | Host Cell Protein Testing Market to Reach USD 1.99 Billion by 2030 – Exclusive Report By SNS Insider | Host Cell Protein Testing Market
Host Cell Protein Testing Market Analysis, Size, Trends, Industry Overview and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 9, 2024 /EINPresswire.com/ -- The Global Host Cell Protein Testing Market is ... |
| 29.08.2023 | US giant lands UK life-science firm Abcam for £4.5bn | A British life-sciences company Abcam has been snapped up by a US medical giant in a £4.5bn deal, writes Emily Hawkins.
Danaher - one of the world's largest suppliers of medical tools - announced it would pay $24 per share in cash for Abcam... |
| 30.03.2023 | Innovation and technology clusters or the Premier League? - The economic impact of the University of Cambridge | When discussing learning outcomes and different contributions of various Universities, there is one very important aspect that needs to be analysed and taken into account when talking about the importance and quality of higher education – t... |
| 12.12.2022 | Abcam plc: Update on AIM Delisting | CAMBRIDGE, England and WALTHAM, Mass., Dec. 12, 2022 /PRNewswire/ -- Abcam plc, ABC and ABCM ("Abcam" or the "Company"), a global leader in the supply of life science research tools, today provides a further update with ... |
| 20.07.2022 | ABCAM PLC First Half Trading Update | CAMBRIDGE, England, July 20, 2022 /PRNewswire/ -- Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following tr... |
| 25.03.2022 | Abcam the most awarded company at 2022 industry awards | CAMBRIDGE, England, March 25, 2022 /PRNewswire/ -- Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This r... |
| 13.01.2022 | Abcam in Glassdoor’s top 5 ‘best places to work in the UK’ for second consecutive year | Abcam in Glassdoor’s top 5 ‘best places to work in the UK’ for second consecutive year
13-01-2022
Abcam, a global innovator empowering life science researchers with high-quality biological reagents and tools critical to research, drug disco... |
| 04.01.2022 | Alamar Biosciences partners with Abcam to drive understanding of the human proteome | FREMONT, Calif. and CAMBRIDGE, England, Jan. 4, 2022 /PRNewswire/ -- Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM:... |
| 02.11.2021 | Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome | SEATTLE and CAMBRIDGE, England, Nov. 2, 2021 /PRNewswire/ -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM... |
| 27.10.2021 | Abcam completes $340m strategic acquisition and expands kit capacity and capability | - Completing $340m strategic acquisition of BioVision
- Expanding facilities in Eugene, further growing kits and assays portfolio
- Supporting the growing demand of the sector and accelerating execution of strategic plan
CAMBRIDGE, England,... |
| 27.10.2021 | Abcam completes $340m strategic acquisition and expands kit capacity and capability | - Completing $340m strategic acquisition of BioVision
- Expanding facilities in Eugene, further growing kits and assays portfolio
- Supporting the growing demand of the sector and accelerating execution of strategic plan
CAMBRIDGE, England,... |
| 13.07.2021 | Abcam : opens new US facility in Boston, MA | CAMBRIDGE, July 13, 2021 /PRNewswire/ -- Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA.
The new facility is a central component of Abc... |
| 23.06.2021 | Pionyr And Abcam Extend Partnership To Evaluate TREM2-Expressing Cells In Cancer Patients | The partnership will support the progression of PY314, the first of Pionyr’s Myeloid Tuning™ antibodies to enter the clinic Pionyr will use Abcam’s EPR20243 clone to evaluate TREM2 levels in tissue samples for potential future development a... |
| 08.12.2020 | Abcam reveals new cell engineering facility in Bay Area
USA - English
USA - English | |
| 23.10.2020 | Abcam raises $180m through US IPO | Abcam raises $180m through US IPO
23-10-2020
Cambridge-based Abcam, which supplies tools globally for life science research, has had a blockbusting response to its IPO on America’s NASDAQ technology exchange.
Read the full article by Tony Q... |
| 23.07.2020 | Abcam update reflects impact of the pandemic | Abcam update reflects impact of the pandemic
23-07-2020
Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, issues an unaudited trading update for the year ended 30 June 2020, ahead of reporting its audited r... |
| 09.07.2020 | Cancer Research UK and Abcam launch custom partnership to accelerate cancer research | Cancer Research UK and Abcam launch custom partnership to accelerate cancer research
09-07-2020
Cancer Research UK, the world's largest independent funder of cancer research and Abcam plc, a global innovator in life science reagents and too... |
| 30.01.2020 | Abcam expands cell engineering capabilities | Abcam expands cell engineering capabilities
30-01-2020
Abcam, a global innovator in life science reagents and tools, today announces the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell, Inc. (A... |
| 17.01.2020 | Peter Ciriello takes over the reins at Vygon USA; Mirum Pharmaceuticals taps Ian Clements to the role of CFO | Peter Ciriello
→ Peter Ciriello has climbed to the upper echelons of the French medical device maker Vygon Group. He will run the company’s US operations from the company’s headquarters in Pennsylvania and is also ta... |
| 11.11.2019 | Abcam agrees to acquire Expedeon’s Proteomics and Immunology business | Abcam agrees to acquire Expedeon’s Proteomics and Immunology business
11-11-2019
Abcam plc (AIM LSE: ABC), a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement to acqu... |
| 22.07.2019 | Abcam reports continuing growth and strong prospects | Abcam reports continuing growth and strong prospects
22-07-2019
Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, today issues an unaudited trading update for the year ended 30 June 2019 ahead of reporting ... |
| 18.07.2019 | Blood purification company Aethlon Medical turns its focus to cancer | The San Diego company’s device consists of a plasmapheresis cartridge filled with hollow fibers allowing for fluid flow and a plant protein called galanthus nivalis agglutinin, which has the ability to bind to certain viral agents.
In its r... |
| 24.01.2019 | Abcam, LouLou Foundation partner to develop key research tools for CDKL5 deficiency disorder | Abcam, LouLou Foundation partner to develop key research tools for CDKL5 deficiency disorder
24-01-2019
Abcam plc, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation dedicated to ... |
| 05.03.2018 | Abcam reports continued strong sales growth, ahead of underlying market rates | Abcam reports continued strong sales growth, ahead of underlying market rates
05-03-2018
Abcam plc (AIM: ABC) a global leader in the supply of life science research tools, is pleased to announce its interim results for the six-month period ... |
| 05.01.2018 | Abcam continues to deliver double-digit revenue growth | Abcam continues to deliver double-digit revenue growth
05-01-2018
Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces an unaudited trading update ahead of its results for the six months ended 31 Dec... |
| 11.09.2017 | Abcam reports double-digit earnings growth, enabling investment for sustained future growth | Abcam reports double-digit earnings growth, enabling investment for sustained future growth
11-09-2017
Abcam plc, a global leader in the supply of life science tools, is pleased to announce its preliminary results for the year ended 30 June... |
| 23.05.2016 | SyndicateRoom raises $4.5M Series A to push for growth in equity capital markets | SyndicateRoom, the U.K. equity crowdfunding platform that last week announced that the world’s first equity-crowdfunded Hollywood film has signed Antonio Banderas to appear in its movie, has some big news of its own today, announcing a £3.1... |
| 07.03.2016 | Abcam delivers sustained double digit revenue growth while investing in the future | Abcam delivers sustained double digit revenue growth while investing in the future
07-03-2016
Abcam plc, a global leader in the supply of life science research tools, announces its interim results for the six-month period ended 31 December ... |
| 10.06.2015 | Abcam launches multiplex miRNA profiling assays | Abcam plc, a global leader in the supply of life science research tools, announced today the launch of a range of multiplex miRNA profiling assays for high-throughput validation of miRNA biomarkers, based on Abcam’s new Firefly™ particle te... |
| 10.06.2015 | Abcam launches multiplex miRNA profiling assays | Abcam launches multiplex miRNA profiling assays
10-06-2015
Abcam plc, a global leader in the supply of life science research tools, announced today the launch of a range of multiplex miRNA profiling assays for high-throughput validation of ... |
| 18.02.2015 | Abcam's Scientist of the Month: Marianne Rots | Abcam's Scientist of the Month: Marianne Rots
18-02-2015
Marianne Rots, Professor of Molecular Epigenetics at the University Medical Center, Groningen, discusses her exciting research on epigenetic editing.
Brief biography Marianne Rots, Ph... |
| 08.01.2015 | Abcam partners with A*STAR’s Institute of Molecular and Cell Biology | Abcam partners with A*STAR’s Institute of Molecular and Cell Biology
08-01-2015
Abcam plc, a global leader in the supply of life science research tools, announced today it has signed an exclusive partnership agreement with the Institute of ... |
| 22.12.2014 | Abcam's Scientist of the Month: Katharine Wrighton | Abcam's Scientist of the Month: Katharine Wrighton
22-12-2014
Have you ever wondered what it is like to be an editor at a high impact journal? Katharine Wrighton, Chief Editor of Nature Reviews Molecular Cell Biology, talks about her journe... |
| 12.12.2014 | Abcam plc announces Board appointment | Abcam plc, a global leader in the supply of life science research tools, is pleased to announce the appointment of Sue Harris as a non-Executive Director on the Abcam Board. Sue will join the Board with immediate effect and will Chair the A... |
| 12.12.2014 | Abcam plc announces Board appointment | Abcam plc announces Board appointment
12-12-2014
Abcam plc, a global leader in the supply of life science research tools, is pleased to announce the appointment of Sue Harris as a non-Executive Director on the Abcam Board. Sue will join the... |
| 12.11.2014 | Abcam Events: 10 year anniversary giveaway | Abcam Events: 10 year anniversary giveaway
12-11-2014
November 2014 is Abcam Events’ 10 Year Anniversary!
The mission of Abcam's events is to help scientists discover more. With a team of six (based in Cambridge, UK and Boston, US), Abcam w... |
| 05.11.2014 | Abcam's Scientist of the Month: John Gurdon | Abcam's Scientist of the Month: John Gurdon
05-11-2014
Professor Sir John Gurdon took some time away from his busy schedule to tell Abcam about his current research interests and thoughts on the future of epigenetics research.
Professor Sir... |
| 29.10.2014 | How to build a billion dollar business | How to build a billion dollar business
29-10-2014
Find out how Abcam became a billion dollar company from its co-founder, Dr David Cleevely, at CfEL's Enterprise Tuesday on 4th November. He'll talk about the lessons for growing successful c... |
| 09.09.2014 | Abcam plc announces appointment of new CEO and Board changes | Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, is pleased to announce the appointment of Alan Hirzel as Chief Executive Officer with immediate effect. Alan will succeed long-serving Chief Executive and c... |
| 09.09.2014 | Abcam plc announces appointment of new CEO and Board changes | Abcam plc announces appointment of new CEO and Board changes
09-09-2014
Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, is pleased to announce the appointment of Alan Hirzel as Chief Executive Officer wit... |
| 03.02.2014 | Abcam announces winner of 15 discoveries contest | Abcam plc, a global leader in the supply of innovative protein research tools, today announced Yali Huang as the winner of its 15 discoveries contest. Ms. Huang conducts her work at the Early Embryo Development lab at the MRC Centre of Rege... |
| 03.02.2014 | Abcam announces winner of 15 discoveries contest | Abcam announces winner of 15 discoveries contest
03-02-2014
Abcam plc, a global leader in the supply of innovative protein research tools, today announced Yali Huang as the winner of its 15 discoveries contest. Ms. Huang conducts her work a... |
| 09.09.2013 | Abcam launches SimpleStep ELISA kits | Abcam launches SimpleStep ELISA kits
09-09-2013
Abcam plc., a producer and distributor of high quality protein research tools, announced today that it has launched a range of SimpleStep™ ELISA kits. The new kits have a greatly simplified pr... |
| 09.09.2013 | Abcam launches SimpleStep ELISA kits | Abcam plc., a producer and distributor of high quality protein research tools, announced today that it has launched a range of SimpleStep™ ELISA kits. The new kits have a greatly simplified protocol when compared to standard multi-step ELIS... |
| 27.06.2013 | Abcam appoints Alan Hirzel as Chief Marketing Officer | Abcam appoints Alan Hirzel as Chief Marketing Officer
27-06-2013
Abcam, a global leader in the supply of protein research tools, announced today that it has appointed Alan Hirzel as Chief Marketing Officer. This is a new position, based at ... |
| 03.04.2013 | Abcam welcomes students from Cambridge Regional College | Abcam welcomes students from Cambridge Regional College
03-04-2013
Abcam Plc., a producer and distributor of high quality protein research tools, welcomed a group of students studying for the BTEC Science Diploma at Cambridge Regional Colle... |
| 12.04.2012 | Chris Evans talks about Bench to Billions | Chris Evans talks about Bench to Billions
12-04-2012
The Remtec team exhibited at the One Nucleus conference Bench to Boardroom in March. Ian Sandison gives a summary of the day...
I have to say Chris was a great speaker and has clearly cre... |
| 07.03.2012 | Sir Christopher Evans on entrepreneurs, life science and knob heads! | Sir Christopher Evans on entrepreneurs, life science and knob heads!
07-03-2012
The British life science industry is thwarted by lack of investment with a slow regulatory process which is impeding its development, said Sir Christopher Evans... |
| 05.01.2010 | Abcam and Cambridge Design Partnership solve a vial and sticky problem | Abcam and Cambridge Design Partnership solve a vial and sticky problem
05-01-2010
A breakthrough in labelling technology promises a 450% increase in throughput for leading antibody supplier, Abcam plc. The innovation, developed by Cambridge... |
| 26.02.2009 | Abcam announces appointment of Non-Executive Deputy Chairman as Cleevely prepares to step... | Abcam announces appointment of Non-Executive Deputy Chairman as Cleevely prepares to step...
26-02-2009
Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, is pleased to announc... |
| 12.11.2007 | Abcam announces laboratory collaboration | Abcam announces laboratory collaboration
12-11-2007
Abcam plc and Beckman Coulter, Inc. have announced a major bioscience collaboration - to create one of the world's most sophisticated, automated systems for the production of monoclonal an... |
| 07.11.2007 | Abcam appoints Chief Financial Officer | Abcam appoints Chief Financial Officer
07-11-2007
Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, is pleased to announce the appointment as Chief Financial Officer of Jeffre... |
| 16.10.2007 | Abcam secures rights to a further 2,700 antibodies | Abcam secures rights to a further 2,700 antibodies
16-10-2007
Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, is pleased to announce it has entered an agreement with a leadi... |
| 07.08.2007 | Abcam announces distribution agreement with Open Biosystems, Inc. | Abcam announces distribution agreement with Open Biosystems, Inc.
07-08-2007
Abcam plc, the rapidly growing bioscience company that markets antibodies via its own online catalogue, today announces that it has entered an agreement with Alaba... |
| 26.10.2006 | Abcam announces plans to scale-up antibody production | Abcam announces plans to scale-up antibody production
26-10-2006
Abcam plc (AIM: ABC), the rapidly growing company that markets antibodies via an online catalogue, will hold its AGM this morning (Thursday) in Cambridge. The Company will giv... |
| 05.07.2006 | Abcam trading update shows strong performance | Abcam trading update shows strong performance
05-07-2006
Abcam plc, a rapidly growing company that markets antibodies via an online catalogue, today provides a trading update for the year ending 30 June 2006 ahead of its preliminary results... |
| 14.02.2006 | Abcam announces interim results for six months to 31 December 2005 | Abcam announces interim results for six months to 31 December 2005
14-02-2006
Abcam plc (AIM: ABC), a rapidly growing bioscience company that markets antibodies via an online catalogue, is pleased to announce its interim results for the six... |
| 23.08.2005 | Queen's Award for Abcam highlights business success | Queen's Award for Abcam highlights business success
23-08-2005
Antibody reagents company Abcam has once again demonstrated the strength of its business by winning a prestigious Queen's Award for Enterprise.
At a presentation ceremony at the... |
| 24.10.2003 | Abcam in Top 5 of the fastest growing companies in the East | Abcam in Top 5 of the fastest growing companies in the East
24-10-2003
Cambridge, UK - October 24, 2003.
.. Abcam, the world's leading web-based supplier of research tools for the post genomic era, has just topped the ranks of the prestigio... |
| 24.02.2003 | Abcam expands into larger premises | Abcam expands into larger premises
24-02-2003
Abcam, the specialist supplier of antibodies and reagents that originated from the University of Cambridge, has just announced that they have expanded into larger premises.
As a result of the in... |
| - | Blood purification company Aethlon Medical turns its focus to cancer | Aethlon Medical grabbed headlines a few years ago when its HemoPurifier blood filtering device was used on an emergency basis to treat a physician who had contracted Ebola while working in West Africa.
The technology was able to reduce the ... |
